Results 111 to 120 of about 6,064 (188)

Lysophospholipid S1P Receptors in Models of Multiple Sclerosis

open access: yesThe FASEB Journal, 2009
Lysophospholipids are small, signaling lipids that are best known through the chemical species sphingosine 1‐phosphate (S1P) and lysophosphatidic acid (LPA). These molecules have been implicated in an increasingly broad range of physiological and pathophysiological roles with therapeutic potential and mediated ...
openaire   +1 more source

Fingolimod for Multiple Sclerosis: Mechanism of Action, Clinical Outcomes, and Future Directions [PDF]

open access: yes, 2018
The oral sphingosine 1-phosphate receptor (S1PR) modulator fingolimod functionally antagonizes S1PR hereby blocking lymphocyte egress from secondary lymphoid organs to the peripheral blood circulation. This results in a reduction in peripheral lymphocyte
Derfuss, Tobias   +2 more
core  

Effects of lysophospholipid supplementation in diets with different oil sources on broiler performance under heat stress. [PDF]

open access: yesFront Vet Sci
Mohiti-Asli M   +4 more
europepmc   +1 more source

ATP-release pannexin channels are gated by lysophospholipids. [PDF]

open access: yesElife
Henze E   +11 more
europepmc   +1 more source

New insights into the crosstalk between endocannabinoids and sphingosine-1-phosphate. [PDF]

open access: yesJ Biol Chem
Rapino C   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy